Key Points

• Pfizer reached a Master Settlement Agreement in June 2026 to resolve many Depo-Provera meningioma lawsuits pending in federal court. 
• The settlement program is designed for women whose cases are already pending, and registration is expected to be completed in November 2026. 
• Women diagnosed with meningioma after using the Depo shot who have not filed a lawsuit may still qualify to take legal action, but filing deadlines continue to apply. 

Why It Matters

The Depo-Provera settlement is moving from an announcement to an active claims process. A court-appointed administrator will soon review medical records, decide who is eligible, and help process payments. Women who have not filed a claim are not currently part of that process. State filing deadlines also continue to run while the settlement moves forward, which means waiting may limit a woman’s legal options. 

Depo-Provera Settlement Moves Toward Registration

Women who used the Depo-Provera birth control shot and were later diagnosed with meningioma brain tumors are following the settlement closely. In June 2026, Pfizer and the attorneys leading the federal Depo-Provera lawsuit litigation announced a global agreement to resolve eligible claims. That agreement has since been signed, and the settlement program is preparing to register claimants. 

Many women who have not filed a lawsuit assume the settlement will include them automatically. It does not. The settlement program is designed for women whose claims are already part of the litigation. Women who have not filed may still qualify to take legal action, and acting early may help protect their options. 

If you or a loved one used Depo-Provera and were diagnosed with a meningioma brain tumor, you may be eligible to file a lawsuit and receive compensation. Contact the lawyers at Hissey Mulderig & Friend toll-free at 1-866-806-8117, or start your Depo-Provera claim today to find out whether you qualify. 

What the Depo-Provera Settlement Agreement Includes

Federal Depo-Provera lawsuits are consolidated in a multidistrict litigation, or MDL, in the U.S. District Court for the Northern District of Florida. An MDL groups similar lawsuits from across the country before one judge for pretrial proceedings. Each woman keeps her own individual case. 

On June 15, 2026, U.S. District Judge M. Casey Rodgers issued an order confirming that plaintiffs’ lead counsel and the Pfizer defendants had reached a global settlement agreement in principle. The parties then signed a Master Settlement Agreement on July 21, 2026, resolving most of the federal claims in MDL 3140.  

A federal report dated August 3, 2026, listed 6,294 pending lawsuits in the MDL. The parties estimated that roughly 80% of MDL plaintiffs would be eligible under the agreement. That figure is the parties’ own estimate. It is not a decision about any individual claim.  

The Master Settlement Agreement is private, and neither its complete eligibility criteria nor its individual payout matrix has been made public. Any specific payment figure published before those terms are released is an estimate, not a confirmed settlement amount.  

When Registration and Payments Are Expected

Registration for the Depo-Provera settlement is expected to be completed in November 2026, and payments are expected to begin by the first quarter of 2027. These dates are projections and may change as the program moves forward. 

Registration is the stage where claimants submit information and medical records to the administrator. After review, the administrator issues eligibility decisions. In most mass tort settlement programs, each eligible claimant then decides whether to accept the offer. 

Can Women Who Have Not Filed Still Take Legal Action?

The court’s order describes the agreement as offering a substantial percentage of plaintiffs with cases pending in the MDL the opportunity to resolve their claims. Women who have not filed a lawsuit are not currently part of that group. 

This does not mean it is too late. Women diagnosed with meningioma after using the Depo shot may still qualify to file a lawsuit. Claims that are not resolved through the settlement continue through the court process. Whether a newly filed case can take part in the settlement program depends on terms that have not been made public.  

If you have questions about your legal options, the lawyers at Hissey Mulderig & Friend can help you review how the program may apply to your claim and explain how the Depo-Provera settlement may affect your legal options. 

Leadership counsel described the settlement as resolving a majority of claims in MDL 3140 and in the related New York litigation. Women with cases pending in other courts should speak with a lawyer about how the agreement may affect them. 

Filing Deadlines Still Apply

Every state sets a deadline, called a statute of limitations, for filing a personal injury lawsuit. In some states, that deadline is as short as one year. The settlement does not pause these deadlines. 

Many states follow the discovery rule. Under this rule, the deadline begins when a person knew, or reasonably should have known, that a product may have caused her injury. The March 2024 BMJ study and the December 2025 FDA warning are relevant notice benchmarks for state filing deadlines.  

Because these filing deadlines vary widely, women should review the Depo-Provera statute of limitations in their state as soon as possible. 

Who May Be Eligible to File a Depo-Provera Lawsuit

Women who used the Depo shot may be eligible to file if they meet the following case criteria: 

1. Used Depo-Provera, Depo-SubQ Provera 104, or a generic medroxyprogesterone acetate injection for birth control; 
2. Received at least one year (four injections) of the Depo shot; 
3. Were diagnosed with a meningioma brain tumor. 

Women who received a generic Depo-Provera shot are not automatically excluded. Women who meet all of the above criteria may qualify to file a lawsuit and receive compensation. 

Records That Help Support a Claim

The settlement administrator will review supporting records closely. Records that may help support a Depo-Provera claim include: 

• Pharmacy or clinic records showing Depo-Provera injections 
• MRI or CT scan reports confirming the meningioma diagnosis 
• Surgical, radiation, or pathology reports 
• Records of follow-up monitoring and treatment 

Women do not need to gather every record before speaking with a lawyer. Learn more about the medical records needed for a Depo-Provera lawsuit. 

Frequently Asked Questions About the Depo-Provera Settlement

Is the Depo-Provera settlement final?

The Master Settlement Agreement has been signed, and the court has appointed a settlement administrator. The eligibility rules and payment amounts have not been released to the public. 

How much will the Depo-Provera settlement pay?

Individual payment amounts have not been made public. Compensation in mass tort settlements often depends on factors such as the type of treatment, the severity of the injury, and the strength of the medical records. 

Is the settlement the same as a class action?

No. The federal Depo-Provera cases are part of an MDL, where each woman keeps her own lawsuit. Eligibility is reviewed claim by claim. 

Do I qualify to file a claim?

Eligibility to file a claim depends on the specifics of each woman’s individual case. An experienced birth control attorney can help you determine whether you qualify with a free case review. 

Contact a Depo-Provera Lawyer Today

If you or a loved one used the Depo-Provera shot and were diagnosed with a meningioma brain tumor, you may be eligible to file a lawsuit and receive compensation.  

Our law firm, Hissey Mulderig & Friend, is currently representing women across the U.S. who have developed meningioma brain tumors or other side effects linked to the Depo-Provera birth control shot.  

If you or a loved one were diagnosed with meningiomas after using the Depo shot, contact our lawyers for a free case evaluation. You can speak with a lawyer by calling our office toll-free at 1-866-806-8117, or by submitting your information using the free contact form located at the top of this page.